Predictive Approaches in Drug Discovery and Development: Biomarkers and In Vitro / In Vivo Correlations [NOOK Book]

Overview

Comprehensive coverage of biomarker research applied to drug discovery and development

Two key factors have emerged in the race to discover approvable new drugs faster and with fewer resources: biomarkers and in vitro/in vivo correlations (IVIVC). Predictive Approaches in Drug Discovery and Development: Biomarkers and In Vitro/In Vivo Correlations provides comprehensive coverage of how these factors are enhancing the drug pipeline and ...

See more details below
Predictive Approaches in Drug Discovery and Development: Biomarkers and In Vitro / In Vivo Correlations

Available on NOOK devices and apps  
  • NOOK Devices
  • Samsung Galaxy Tab 4 NOOK
  • NOOK HD/HD+ Tablet
  • NOOK
  • NOOK Color
  • NOOK Tablet
  • Tablet/Phone
  • NOOK for Windows 8 Tablet
  • NOOK for iOS
  • NOOK for Android
  • NOOK Kids for iPad
  • PC/Mac
  • NOOK for Windows 8
  • NOOK for PC
  • NOOK for Mac
  • NOOK for Web

Want a NOOK? Explore Now

NOOK Book (eBook)
$79.99
BN.com price
(Save 42%)$140.00 List Price
Note: This NOOK Book can be purchased in bulk. Please email us for more information.

Overview

Comprehensive coverage of biomarker research applied to drug discovery and development

Two key factors have emerged in the race to discover approvable new drugs faster and with fewer resources: biomarkers and in vitro/in vivo correlations (IVIVC). Predictive Approaches in Drug Discovery and Development: Biomarkers and In Vitro/In Vivo Correlations provides comprehensive coverage of how these factors are enhancing the drug pipeline and accelerating development.

An invaluable resource, the book presents essential information on the importance of biomarkers in translational medicine, the clinical applications of biomarkers, relevant regulatory perspectives, and the potential of in vivo research. With each chapter written by one or more expert authors from the global front lines of the pharmaceutical industry and regulatory agencies, the book also incorporates academic research that unites these two fields and describes their applications, from technical lab experiments to strategic management.

Covering many aspects of biomarker research as applied to drug discovery and development, the book brings together state-of-the-art appraisals of the practical utility of "-omics", biochemical, and protein biomarkers with case histories and lessons from successful and unsuccessful real-world applications. Regulatory agency perspectives and initiatives in the United States and around the world are also discussed, as are GLP validation and, safety biomarkers, and proteomic biomarkers.

Biomarkers and IVIVC present unique opportunities for identifying more robust clinical candidates and selecting leads more intelligently, making Predictive Approaches in Drug Discovery and Development a must-have for researchers and professionals in the pharmaceutical and biotechnology industries, as well as for use in advanced graduate and undergraduate courses.

Read More Show Less

Editorial Reviews

From the Publisher
“The ability to correlate in vitro and in vivo biomarker information in the process of drug discovery and development lies at the heart of translational research. The goal is to rapidly translate basic discoveries into clinical applications. This book provides state-of-the-art information on this exciting new research approach.” (Doody’s, 8 February 2013)

“The text is packed with interesting, comprehensive, and pertinent information, clearly presented with salient points reinforced by inclusion in text boxes . . . This is an admirable textbook for those dealing with drug discovery and development. I enjoyed reading through it and I would recommend it to anyone who has an interest, or is developing an interest, in the field of biomarkers and their, as yet, unfulfilled potential.” (ISSX International Society for the Study of Xenobiotics, 1 December 2012)

Doody's Review Service
Reviewer: Thomas L. Pazdernik, PhD (University of Kansas Medical Center)
Description: Translational research is a current buzz word that deals with bringing bench research to the bedside. This book in the Wiley Series on Technologies for the Pharmaceutical Industry focuses on the use of in vitro and in vivo biomarkers to facilitate drug discovery and development.
Purpose: The editors' objective is to provide a critical compilation of the most important aspects of the use of in vitro and in vivo biomarkers to facilitate translating basic pharmacology and drug effects into clinical utility and regulatory acceptance. They have done a marvelous job of bringing these correlations together.
Audience: This book is designed to be of value to all those in academia or the pharmaceutical industry who are involved in the process of new drug discovery all the way from concepts, "go-to-no-go" decision processes, and regulatory aspects.
Features: Part I deals with the use of biomarkers in drug discovery including importance, validation, and proteomic and metabolomics methods. Part II focuses on clinical applications of biomarkers including vascular biomarkers and imaging, success and failure in the prediction human safety via cardiovascular biomarkers, the use of molecular imaging for receptor occupancy for decision making in drug discovery, and the use of biosensors as clinical markers. Part III deals with regulatory perspectives and includes chapters providing European and Japanese perspectives. Part IV covers predicting responses in vivo such as in vitro/in vivo correlations of hepatic drug clearance, the potential of a combination of in silico and in vitro approaches to predict in vivo drug-drug interactions, pharmacokinetics, and toxicity; and the use of in vitro/in vivo correlations for developing concepts and applications in toxicology, plus assessing the potential for induction of cytochrome p450 enzymes and predicting in vivo metabolism.
Assessment: The ability to correlate in vitro and in vivo biomarker information in the process of drug discovery and development lies at the heart of translational research. The goal is to rapidly translate basic discoveries into clinical applications. This book provides state-of-the-art information on this exciting new research approach.
Read More Show Less

Product Details

Meet the Author

J. Andrew Williams, PHD, is Director of Translational Oncology at Pfizer Oncology.

Richard Lalonde, PharmD, is Vice President and Global Head of Clinical Pharmacology at Pfizer.

Jeffrey Koup, PharmD, is a consultant for PKPD modeling and the owner of Lakeside PKPD, LLC.

David D. Christ, PHD, is a consultant with SNC Partners LLC.

Read More Show Less

Table of Contents

PREFACE xi

ACKNOWLEDGMENTS xiii

CONTRIBUTORS xv

PART I BIOMARKERS IN DRUG DISCOVERY 1

1 The Importance of Biomarkers in Translational Medicine 3
Joseph C. Fleishaker

2 Validation of Biochemical Biomarker Assays used in Drug Discovery and Development: A Review of Challenges and Solutions 23
Gabriella Szekely-Klepser and Scott Fountain

3 Proteomic Methods to Develop Protein Biomarkers 49
Ruth A. VanBogelen and Diane Alessi

4 Overview of Metabolomics Basics 79
Qiuwei Xu and William H. Schaefer

PART II CLINICAL APPLICATION OF BIOMARKERS 139

5 Vascular Biomarkers and Imaging Studies 141
Karin Potthoff, Ulrike Fiedler, and Joachim Drevs

6 Cardiovascular Biomarkers as Examples of Success and Failure in Predicting Safety in Humans 163
Simon Authier, Michael K. Pugsley, Eric Troncy, and Michael J. Curtis

7 The Use of Molecular Imaging for Receptor Occupancy Decision Making in Drug Development 189
Ralph Paul Maguire

8 Biosensors for Clinical Biomarkers 203
Sara Tombelli and Marco Mascini

PART III REGULATORY PERSPECTIVES 229

9 Regulatory Perspectives on Biomarker Development 231
Rajanikanth Madabushi, Lawrence Lesko, and Janet Woodcock

10 Perspectives from the European Regulatory Authorities 255
Ian Hudson

11 Use of Biomarker in Drug Development—Japanese
Perspectives 269
Yoshiaki Uyama, Akihiro Ishiguro, Harumasa Nakamura,and Satoshi Toyoshima

PART IV PREDICTING IN VIVO 289

12 In VitroIn Vivo Correlations of Hepatic Drug Clearance 291
R. Scott Obach

13 The Potential of In Silico and In Vitro Approaches to Predict In Vivo Drug–Drug Interactions and ADMET/TOX Properties 307
Kenneth Bachmann and Sean Ekins

14 In VitroIn Vivo Correlations in Drug Discovery and Development: Concepts and Applications in Toxicology 331
Rex Denton, Kimberly Brannen, and Bruce D. Car

15 Assessing the Potential for Induction of Cytochrome P450 Enzymes and Predicting the In Vivo Response 353
Jiunn H. Lin

INDEX 383

Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star

(0)

4 Star

(0)

3 Star

(0)

2 Star

(0)

1 Star

(0)

Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation

Reminder:

  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

 
Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously

    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)